EFFECT OF PREOPERATIVE ANTICOAGULANT TREATMENT ON ACTIVATED COAGULATION TIME AND HEPARIN LEVELS DURING NORMOTHERMIC CARDIOPULMONARY BYPASS (CPB)

被引：0
|
作者：
LONGROIS, D
GONCALVES, O
DEPOIX, JP
ENGUERAND, D
PHILIP, Y
MONTRAVERS, P
CHATEL, D
HVASS, U
DESMONTS, JM
机构：
[1] HOP BICHAT,DEPT ANESTHESIA,PARIS,FRANCE
[2] HOP BICHAT,DEPT CARDIOVASC SURG,PARIS,FRANCE
来源：
BRITISH JOURNAL OF ANAESTHESIA | 1995年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [1] EFFECT OF PREOPERATIVE ANTI-COAGULANT TREATMENT ON ACTIVATED COAGULATION TIME AND HEPARIN LEVELS DURING NORMOTHERMIC CARDIOPULMONARY BYPASS
    LONGROIS, D
    GONCALVES, O
    DEPOIX, JP
    ENGUERAND, D
    PHILIP, I
    MONTRAVERS, P
    HVASS, U
    BRIDEY, F
    DEPROOST, D
    DESMONTS, JM
    ANESTHESIOLOGY, 1995, 83 (3A) : A93 - A93
  • [2] ACTIVATED COAGULATION TIME METHOD FOR CONTROL OF HEPARIN IS RELIABLE DURING CARDIOPULMONARY BYPASS
    COHEN, JA
    ANESTHESIOLOGY, 1984, 60 (02) : 121 - 124
  • [3] HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS (CPB)
    SALEHSHENAQ, S
    SALEEM, A
    YAWN, D
    HARSBERGER, K
    DIEMUNSCH, P
    MOHINDRA, P
    ANESTHESIA AND ANALGESIA, 1984, 63 (02): : 271 - 271
  • [4] Heparin management during normothermic cardiopulmonary bypass
    Wouters, PF
    Casteleyn, T
    Sergeant, P
    Meyns, B
    Arout, J
    ANESTHESIA AND ANALGESIA, 2000, 90 (02): : U75 - U75
  • [5] Use of a low molecular weight heparin (enoxaparin) as an anticoagulant for cardiopulmonary bypass (CPB).
    Lutz, P
    Moody, C
    Levitsky, S
    BLOOD, 1996, 88 (10) : 3064 - 3064
  • [6] ACTIVATED CLOTTING TIME AND HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS
    SWAANENBURG, JCJM
    BRENKEN, U
    BAKKER, HAM
    CLINICAL CHEMISTRY, 1990, 36 (06) : 975 - 975
  • [7] Selective convective brain cooling during normothermic cardiopulmonary bypass (CPB) in dogs
    Waggoner, JR
    Wass, T
    Cable, D
    Schaff, H
    Lanier, W
    Schroeder, D
    ANESTHESIOLOGY, 1997, 87 (03) : A678 - A678
  • [8] Advantages of low dose heparin and heparin bonded surfaces during cardiopulmonary bypass (CPB)
    Khuri, SF
    Healey, NA
    Hassanein, WH
    Birjiniuk, V
    Crittenden, MD
    Tyrrell, TA
    Treanor, PA
    Bauer, K
    Valeri, R
    CIRCULATION, 1998, 98 (17) : 526 - 526
  • [9] CONTROL OF HEPARINIZATION DURING CARDIOPULMONARY BYPASS BASED ON ACTIVATED COAGULATION TIME
    IKOMA, Y
    HIRAI, K
    AOYAMA, Y
    ARAKI, T
    ITO, K
    NAKAMURA, K
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1978, 42 (06): : 738 - 739
  • [10] Monitoring heparin effect during cardiopulmonary bypass (CPB):: The ACT II® and Hemochron® instruments are not interchangeable
    Bélisle, S
    Brault, S
    Hardy, JF
    ANESTHESIA AND ANALGESIA, 2000, 90 (02):
12345